Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-09-16

AUTHORS

Waleed Arafat, Tong Zhou, George E. Naoum, Donald J. Buchsbaum

ABSTRACT

TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) induces a death signal following binding to death receptors (DR4, DR5). We have developed a novel anti-human DR-5 monoclonal antibody (TRA-8) and adenoviral encoding TRAIL (Ad/TRAIL). Herein, we are testing the combined effect of radiotherapy and TRA-8 or Ad TRAIL in prostate cancer cells. Human prostate cancer cell lines LnCap, PC-3 and DU145 were used in this study. Cells were treated either with TRA-8 alone or Ad/TRAIL, radiation alone, or a combination of each at different doses and intervals. Cell survival using the MTS assay and colony forming assay were used to determine radiosensitization. Immunohistochemistry was used to detect bax and bcl-2. Real-time PCR was performed on mRNA of treated prostate cancer cell lines. Finally, a murine model of subcutaneous prostate cancer was used to evaluate the in vivo effect. Cell survival assays detected by MTS assay showed that prostate cell lines treated with a combination of radiation and TRA-8 showed significantly lower survival than cells treated with either radiation or TRA-8 alone. Colony forming assay and cell proliferation assays showed increased killing after combination treatment with TRA-8 or Ad/TRAIL and radiation, than either single agent alone. Mechanistic studies showed that the killing effect was due to induction of apoptosis mostly by increased expression of bax in TRA-8 or Ad/TRAIL treated cells. Additionally, RT-PCR showed an increased copy number of bax in most cells treated with TRA-8 and radiation. It is concluded that radiation and TRA-8 or Ad/TRAIL produced a synergistic effect in refractory prostrate cancer. More... »

PAGES

205-215

Identifiers

URI

http://scigraph.springernature.com/pub.10.1016/j.jnci.2015.08.003

DOI

http://dx.doi.org/10.1016/j.jnci.2015.08.003

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023665545

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26385392


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Stem Cell Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "bcl-2-Associated X Protein", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Alabama at Birmingham, Birmingham, AL, United States", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Alexandria University, Oncology Department, Egypt", 
            "University of Alabama at Birmingham, Birmingham, AL, United States"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arafat", 
        "givenName": "Waleed", 
        "id": "sg:person.01340374430.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340374430.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Tong", 
        "id": "sg:person.0664616100.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alexandria Comprehensive Cancer Center, Research Department, Egypt", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Alexandria Comprehensive Cancer Center, Research Department, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Naoum", 
        "givenName": "George E.", 
        "id": "sg:person.01075546537.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075546537.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL, United States", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Radiation Oncology, Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL, United States"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buchsbaum", 
        "givenName": "Donald J.", 
        "id": "sg:person.01137705050.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137705050.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/75045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044338034", 
          "https://doi.org/10.1038/75045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/91000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047281881", 
          "https://doi.org/10.1038/91000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00253-013-5227-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025940409", 
          "https://doi.org/10.1007/s00253-013-5227-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1204318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002566386", 
          "https://doi.org/10.1038/sj.onc.1204318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/86397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004368073", 
          "https://doi.org/10.1038/86397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010598958", 
          "https://doi.org/10.1038/5517"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-09-16", 
    "datePublishedReg": "2015-09-16", 
    "description": "TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) induces a death signal following binding to death receptors (DR4, DR5). We have developed a novel anti-human DR-5 monoclonal antibody (TRA-8) and adenoviral encoding TRAIL (Ad/TRAIL). Herein, we are testing the combined effect of radiotherapy and TRA-8 or Ad TRAIL in prostate cancer cells. Human prostate cancer cell lines LnCap, PC-3 and DU145 were used in this study. Cells were treated either with TRA-8 alone or Ad/TRAIL, radiation alone, or a combination of each at different doses and intervals. Cell survival using the MTS assay and colony forming assay were used to determine radiosensitization. Immunohistochemistry was used to detect bax and bcl-2. Real-time PCR was performed on mRNA of treated prostate cancer cell lines. Finally, a murine model of subcutaneous prostate cancer was used to evaluate the in vivo effect. Cell survival assays detected by MTS assay showed that prostate cell lines treated with a combination of radiation and TRA-8 showed significantly lower survival than cells treated with either radiation or TRA-8 alone. Colony forming assay and cell proliferation assays showed increased killing after combination treatment with TRA-8 or Ad/TRAIL and radiation, than either single agent alone. Mechanistic studies showed that the killing effect was due to induction of apoptosis mostly by increased expression of bax in TRA-8 or Ad/TRAIL treated cells. Additionally, RT-PCR showed an increased copy number of bax in most cells treated with TRA-8 and radiation. It is concluded that radiation and TRA-8 or Ad/TRAIL produced a synergistic effect in refractory prostrate cancer. ", 
    "genre": "article", 
    "id": "sg:pub.10.1016/j.jnci.2015.08.003", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1106642", 
        "issn": [
          "1110-0362", 
          "2589-0409"
        ], 
        "name": "Journal of the Egyptian National Cancer Institute", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "Ad/TRAIL", 
      "TRA-8", 
      "prostate cancer", 
      "monoclonal antibodies", 
      "human prostate cancer cell line LNCaP", 
      "prostate cancer cell line LNCaP", 
      "prostate cancer cell lines", 
      "effect of radiotherapy", 
      "cancer cell line LNCaP", 
      "prostate cancer cells", 
      "cell line LNCaP", 
      "cell lines", 
      "combination of radiation", 
      "prostate cell lines", 
      "expression of Bax", 
      "cell survival assay", 
      "Ad-TRAIL", 
      "cancer cell lines", 
      "cell proliferation assays", 
      "real-time PCR", 
      "murine model", 
      "vivo effects", 
      "combination treatment", 
      "single agent", 
      "soluble TRAIL", 
      "induction of apoptosis", 
      "prostrate cancer", 
      "Targeted radiotherapy", 
      "colony forming", 
      "different doses", 
      "proliferation assays", 
      "survival assays", 
      "RT-PCR", 
      "cancer cells", 
      "PC-3", 
      "cancer", 
      "Bcl-2", 
      "radiotherapy", 
      "cell survival", 
      "death receptors", 
      "antibodies", 
      "Bax", 
      "lower survival", 
      "most cells", 
      "survival", 
      "cells", 
      "assays", 
      "death signals", 
      "immunohistochemistry", 
      "LNCaP", 
      "doses", 
      "DU145", 
      "receptors", 
      "copy number", 
      "MTS", 
      "mechanistic studies", 
      "effect", 
      "radiosensitization", 
      "adenovirus", 
      "treatment", 
      "synergistic effect", 
      "apoptosis", 
      "study", 
      "induction", 
      "cytotoxicity", 
      "trails", 
      "PCR", 
      "mRNA", 
      "agents", 
      "expression", 
      "combination", 
      "intervals", 
      "lines", 
      "radiation", 
      "number", 
      "Herein", 
      "colonies", 
      "model", 
      "signals", 
      "forming"
    ], 
    "name": "Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer", 
    "pagination": "205-215", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023665545"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1016/j.jnci.2015.08.003"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26385392"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1016/j.jnci.2015.08.003", 
      "https://app.dimensions.ai/details/publication/pub.1023665545"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_654.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1016/j.jnci.2015.08.003"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/j.jnci.2015.08.003'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/j.jnci.2015.08.003'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/j.jnci.2015.08.003'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/j.jnci.2015.08.003'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      22 PREDICATES      134 URIs      120 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1016/j.jnci.2015.08.003 schema:about N081260cfde604f88b60110757727b9e5
2 N0e32412208b44d74bafc711c383fa858
3 N121121f816284fc5b77ea4af13a4fcd4
4 N206815aadc8c4205964c5a41d1bfb62f
5 N26bd2c11740b4107a8d119bee3df4b27
6 N30a4ed8344094c14a45fd4c65b0ce747
7 N38810bb9d99d488fb32e811e95a11fb3
8 N3a618a9bfe2b4ce292f06b442ef6a702
9 N50539a44f66c49cf84a66fc6604fc2c8
10 N52c4803f1b184063ad9341f66fbe72c5
11 N65e468d6c87f4848bbcbf1cc5bf4a250
12 N6ad3309be8be4e8095fbe9609e15a498
13 N70733d1cfe194159ac9690b3394f828d
14 N7ee9e19097b5402993505dd7322dcdb0
15 Nb31a247a25a443a28240f292616468e9
16 Nb5aa1e242dd34318b768bf27e349d4ba
17 Nb9774cdbb012485bbe244b8fbbecd6ad
18 Nc0a8bad5fe5740ceb5e4b5b47ca34f42
19 Nc3433c1f46b7475eb3b9ea1aef8c371e
20 Nd651a5316ecd441fb642bec084f69e52
21 Nf2d4f0dda63540afbba6c2df211369e2
22 Nff8e0350caee44ed8cebdebbc38e5a9a
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Nff2592d977744e28ad5c3b0ab020c64f
26 schema:citation sg:pub.10.1007/s00253-013-5227-9
27 sg:pub.10.1038/5517
28 sg:pub.10.1038/75045
29 sg:pub.10.1038/86397
30 sg:pub.10.1038/91000
31 sg:pub.10.1038/sj.onc.1204318
32 schema:datePublished 2015-09-16
33 schema:datePublishedReg 2015-09-16
34 schema:description TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) induces a death signal following binding to death receptors (DR4, DR5). We have developed a novel anti-human DR-5 monoclonal antibody (TRA-8) and adenoviral encoding TRAIL (Ad/TRAIL). Herein, we are testing the combined effect of radiotherapy and TRA-8 or Ad TRAIL in prostate cancer cells. Human prostate cancer cell lines LnCap, PC-3 and DU145 were used in this study. Cells were treated either with TRA-8 alone or Ad/TRAIL, radiation alone, or a combination of each at different doses and intervals. Cell survival using the MTS assay and colony forming assay were used to determine radiosensitization. Immunohistochemistry was used to detect bax and bcl-2. Real-time PCR was performed on mRNA of treated prostate cancer cell lines. Finally, a murine model of subcutaneous prostate cancer was used to evaluate the in vivo effect. Cell survival assays detected by MTS assay showed that prostate cell lines treated with a combination of radiation and TRA-8 showed significantly lower survival than cells treated with either radiation or TRA-8 alone. Colony forming assay and cell proliferation assays showed increased killing after combination treatment with TRA-8 or Ad/TRAIL and radiation, than either single agent alone. Mechanistic studies showed that the killing effect was due to induction of apoptosis mostly by increased expression of bax in TRA-8 or Ad/TRAIL treated cells. Additionally, RT-PCR showed an increased copy number of bax in most cells treated with TRA-8 and radiation. It is concluded that radiation and TRA-8 or Ad/TRAIL produced a synergistic effect in refractory prostrate cancer.
35 schema:genre article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N6a74129598d64540a9a9b90adfaf85ea
39 N899d9af69e174172aec2d830655bd330
40 sg:journal.1106642
41 schema:keywords Ad-TRAIL
42 Ad/TRAIL
43 Bax
44 Bcl-2
45 DU145
46 Herein
47 LNCaP
48 MTS
49 PC-3
50 PCR
51 RT-PCR
52 TRA-8
53 Targeted radiotherapy
54 adenovirus
55 agents
56 antibodies
57 apoptosis
58 assays
59 cancer
60 cancer cell line LNCaP
61 cancer cell lines
62 cancer cells
63 cell line LNCaP
64 cell lines
65 cell proliferation assays
66 cell survival
67 cell survival assay
68 cells
69 colonies
70 colony forming
71 combination
72 combination of radiation
73 combination treatment
74 copy number
75 cytotoxicity
76 death receptors
77 death signals
78 different doses
79 doses
80 effect
81 effect of radiotherapy
82 expression
83 expression of Bax
84 forming
85 human prostate cancer cell line LNCaP
86 immunohistochemistry
87 induction
88 induction of apoptosis
89 intervals
90 lines
91 lower survival
92 mRNA
93 mechanistic studies
94 model
95 monoclonal antibodies
96 most cells
97 murine model
98 number
99 proliferation assays
100 prostate cancer
101 prostate cancer cell line LNCaP
102 prostate cancer cell lines
103 prostate cancer cells
104 prostate cell lines
105 prostrate cancer
106 radiation
107 radiosensitization
108 radiotherapy
109 real-time PCR
110 receptors
111 signals
112 single agent
113 soluble TRAIL
114 study
115 survival
116 survival assays
117 synergistic effect
118 trails
119 treatment
120 vivo effects
121 schema:name Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer
122 schema:pagination 205-215
123 schema:productId N3077791543f34d8c8d6475bf357ca3a5
124 N76bf8481958a48999226c36017e90dfc
125 Nd924dc863e564adf8a9c7b6ff5d50eb7
126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023665545
127 https://doi.org/10.1016/j.jnci.2015.08.003
128 schema:sdDatePublished 2022-05-10T10:09
129 schema:sdLicense https://scigraph.springernature.com/explorer/license/
130 schema:sdPublisher N6be8032cc5fe417e957c888c8e486c9d
131 schema:url https://doi.org/10.1016/j.jnci.2015.08.003
132 sgo:license sg:explorer/license/
133 sgo:sdDataset articles
134 rdf:type schema:ScholarlyArticle
135 N081260cfde604f88b60110757727b9e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Drug Synergism
137 rdf:type schema:DefinedTerm
138 N0e32412208b44d74bafc711c383fa858 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Gene Dosage
140 rdf:type schema:DefinedTerm
141 N121121f816284fc5b77ea4af13a4fcd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Tumor Stem Cell Assay
143 rdf:type schema:DefinedTerm
144 N206815aadc8c4205964c5a41d1bfb62f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Prostatic Neoplasms
146 rdf:type schema:DefinedTerm
147 N26bd2c11740b4107a8d119bee3df4b27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Disease Models, Animal
149 rdf:type schema:DefinedTerm
150 N3077791543f34d8c8d6475bf357ca3a5 schema:name pubmed_id
151 schema:value 26385392
152 rdf:type schema:PropertyValue
153 N30a4ed8344094c14a45fd4c65b0ce747 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cell Proliferation
155 rdf:type schema:DefinedTerm
156 N38810bb9d99d488fb32e811e95a11fb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Mice
158 rdf:type schema:DefinedTerm
159 N3a618a9bfe2b4ce292f06b442ef6a702 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Transcription, Genetic
161 rdf:type schema:DefinedTerm
162 N50539a44f66c49cf84a66fc6604fc2c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Radiotherapy
164 rdf:type schema:DefinedTerm
165 N52c4803f1b184063ad9341f66fbe72c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Xenograft Model Antitumor Assays
167 rdf:type schema:DefinedTerm
168 N57723057123f423fb63400918f4fce11 rdf:first sg:person.0664616100.38
169 rdf:rest Nbe4d2902fefd430d81ddf1ea612f4791
170 N65e468d6c87f4848bbcbf1cc5bf4a250 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Animals
172 rdf:type schema:DefinedTerm
173 N6a74129598d64540a9a9b90adfaf85ea schema:issueNumber 4
174 rdf:type schema:PublicationIssue
175 N6ad3309be8be4e8095fbe9609e15a498 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Drug Resistance, Neoplasm
177 rdf:type schema:DefinedTerm
178 N6be8032cc5fe417e957c888c8e486c9d schema:name Springer Nature - SN SciGraph project
179 rdf:type schema:Organization
180 N70733d1cfe194159ac9690b3394f828d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Apoptosis
182 rdf:type schema:DefinedTerm
183 N76bf8481958a48999226c36017e90dfc schema:name doi
184 schema:value 10.1016/j.jnci.2015.08.003
185 rdf:type schema:PropertyValue
186 N7ee9e19097b5402993505dd7322dcdb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Genes, bcl-2
188 rdf:type schema:DefinedTerm
189 N899d9af69e174172aec2d830655bd330 schema:volumeNumber 27
190 rdf:type schema:PublicationVolume
191 Nb31a247a25a443a28240f292616468e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Gene Expression Regulation, Neoplastic
193 rdf:type schema:DefinedTerm
194 Nb5aa1e242dd34318b768bf27e349d4ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Cell Survival
196 rdf:type schema:DefinedTerm
197 Nb9774cdbb012485bbe244b8fbbecd6ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Antibodies, Monoclonal
199 rdf:type schema:DefinedTerm
200 Nbe4d2902fefd430d81ddf1ea612f4791 rdf:first sg:person.01075546537.05
201 rdf:rest Ncf267f20e4e1463c812376e820233542
202 Nc0a8bad5fe5740ceb5e4b5b47ca34f42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name TNF-Related Apoptosis-Inducing Ligand
204 rdf:type schema:DefinedTerm
205 Nc3433c1f46b7475eb3b9ea1aef8c371e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Male
207 rdf:type schema:DefinedTerm
208 Ncf267f20e4e1463c812376e820233542 rdf:first sg:person.01137705050.57
209 rdf:rest rdf:nil
210 Nd651a5316ecd441fb642bec084f69e52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name bcl-2-Associated X Protein
212 rdf:type schema:DefinedTerm
213 Nd924dc863e564adf8a9c7b6ff5d50eb7 schema:name dimensions_id
214 schema:value pub.1023665545
215 rdf:type schema:PropertyValue
216 Nf2d4f0dda63540afbba6c2df211369e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Cell Line, Tumor
218 rdf:type schema:DefinedTerm
219 Nff2592d977744e28ad5c3b0ab020c64f rdf:first sg:person.01340374430.49
220 rdf:rest N57723057123f423fb63400918f4fce11
221 Nff8e0350caee44ed8cebdebbc38e5a9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Humans
223 rdf:type schema:DefinedTerm
224 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
225 schema:name Medical and Health Sciences
226 rdf:type schema:DefinedTerm
227 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
228 schema:name Oncology and Carcinogenesis
229 rdf:type schema:DefinedTerm
230 sg:journal.1106642 schema:issn 1110-0362
231 2589-0409
232 schema:name Journal of the Egyptian National Cancer Institute
233 schema:publisher Springer Nature
234 rdf:type schema:Periodical
235 sg:person.01075546537.05 schema:affiliation grid-institutes:None
236 schema:familyName Naoum
237 schema:givenName George E.
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075546537.05
239 rdf:type schema:Person
240 sg:person.01137705050.57 schema:affiliation grid-institutes:grid.265892.2
241 schema:familyName Buchsbaum
242 schema:givenName Donald J.
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137705050.57
244 rdf:type schema:Person
245 sg:person.01340374430.49 schema:affiliation grid-institutes:grid.265892.2
246 schema:familyName Arafat
247 schema:givenName Waleed
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340374430.49
249 rdf:type schema:Person
250 sg:person.0664616100.38 schema:affiliation grid-institutes:grid.265892.2
251 schema:familyName Zhou
252 schema:givenName Tong
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38
254 rdf:type schema:Person
255 sg:pub.10.1007/s00253-013-5227-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025940409
256 https://doi.org/10.1007/s00253-013-5227-9
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/5517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010598958
259 https://doi.org/10.1038/5517
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/75045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044338034
262 https://doi.org/10.1038/75045
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/86397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004368073
265 https://doi.org/10.1038/86397
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/91000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047281881
268 https://doi.org/10.1038/91000
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/sj.onc.1204318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002566386
271 https://doi.org/10.1038/sj.onc.1204318
272 rdf:type schema:CreativeWork
273 grid-institutes:None schema:alternateName Alexandria Comprehensive Cancer Center, Research Department, Egypt
274 schema:name Alexandria Comprehensive Cancer Center, Research Department, Egypt
275 rdf:type schema:Organization
276 grid-institutes:grid.265892.2 schema:alternateName Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
277 Department of Radiation Oncology, Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL, United States
278 University of Alabama at Birmingham, Birmingham, AL, United States
279 schema:name Alexandria University, Oncology Department, Egypt
280 Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
281 Department of Radiation Oncology, Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL, United States
282 University of Alabama at Birmingham, Birmingham, AL, United States
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...